🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1861)
All (1861)
Buys (167)
Sells (1694)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
iBio, Inc.
(IBIO)
Brenner Martin
— Director
Mar 19, 2026
Purchase
Shares
12,336
Price
$2.02
Total Value
$24.92K
Shares Held After
30,652
% of Holdings
40.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Mazumdar Claire
— Director
Mar 19, 2026
Sale
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VIEMED HEALTHCARE, INC.
(VMD)
Moore Michael
— President
Mar 19, 2026
Sale
Shares
40,232
Price
$9.21
Total Value
$370.54K
Shares Held After
1,650,812
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aldeyra Therapeutics, Inc.
(ALDX)
DOUGLAS RICHARD
— Director
Mar 19, 2026
Purchase
Shares
70,000
Price
$1.40
Total Value
$98.00K
Shares Held After
195,000
% of Holdings
35.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 19, 2026
Sale
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Xu Zhenyu
— Chief Scientific Officer
Mar 19, 2026
Sale
Shares
608
Price
$4.78
Total Value
$2.91K
Shares Held After
537,116
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
CARDOZA GEORGE
— Chief Financial Officer
Mar 19, 2026
Sale
Shares
774
Price
$4.79
Total Value
$3.70K
Shares Held After
184,858
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Valente Manuela
— Chief People Officer
Mar 19, 2026
Sale
Shares
380
Price
$4.79
Total Value
$1.82K
Shares Held After
152,379
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Menu Philippe
— Chief Medical Officer
Mar 19, 2026
Sale
Shares
608
Price
$4.79
Total Value
$2.91K
Shares Held After
173,616
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Van Well Daan
— Chief Legal Officer
Mar 19, 2026
Sale
Shares
684
Price
$4.79
Total Value
$3.27K
Shares Held After
261,238
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Mar 19, 2026
Sale
Shares
4,533
Price
$144.11
Total Value
$653.25K
Shares Held After
301,185
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Mar 19, 2026
Sale
Shares
4,537
Price
$143.42
Total Value
$650.70K
Shares Held After
305,718
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INSMED Inc
(INSM)
Lewis William
— Director
Mar 19, 2026
Sale
Shares
1,629
Price
$142.17
Total Value
$231.59K
Shares Held After
310,255
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Puylaert Kevin
— Chief Sales Officer
Mar 19, 2026
Sale
Shares
33
Price
$4.76
Total Value
$157.08
Shares Held After
92,386
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Mar 19, 2026
Sale
Shares
4,486
Price
$4.77
Total Value
$21.41K
Shares Held After
3,302,839
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Muken Ross
— President
Mar 19, 2026
Sale
Shares
1,183
Price
$4.79
Total Value
$5.67K
Shares Held After
271,910
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HENRY SCHEIN INC
(HSIC)
Popeck Thomas C
— CEO, Henry Schein Products
Mar 19, 2026
Sale
Shares
1,355
Price
$72.79
Total Value
$98.63K
Shares Held After
86,182
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Serina Therapeutics, Inc.
(SER)
Moreadith Randall
— Chief Scientific Officer
Mar 19, 2026
Sale
Shares
39,000
Price
$2.50
Total Value
$97.50K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Airsculpt Technologies, Inc.
(AIRS)
Chernett Jorey
— 10% Owner
Mar 19, 2026
Purchase
Shares
77,702
Price
$2.64
Total Value
$205.13K
Shares Held After
6,753,761
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuronetics, Inc.
(STIM)
Chernett Jorey
— 10% Owner
Mar 19, 2026
Purchase
Shares
450,000
Price
$1.33
Total Value
$598.50K
Shares Held After
8,573,804
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Mar 19, 2026
Sale
Shares
124
Price
$53.24
Total Value
$6.60K
Shares Held After
73,320
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Mar 19, 2026
Sale
Shares
4,977
Price
$52.79
Total Value
$262.72K
Shares Held After
73,444
% of Holdings
6.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Mar 19, 2026
Sale
Shares
1,939
Price
$51.78
Total Value
$100.41K
Shares Held After
78,421
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Cislini Jeff
— General Counsel
Mar 19, 2026
Sale
Shares
1,163
Price
$97.44
Total Value
$113.32K
Shares Held After
58,518
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Azamian Bobak R.
— Director
Mar 19, 2026
Sale
Shares
11,964
Price
$67.00
Total Value
$801.59K
Shares Held After
33,421
% of Holdings
26.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Phreesia, Inc.
(PHR)
Pale Fire Capital SE
— 10% Owner
Mar 19, 2026
Purchase
Shares
780,009
Price
$11.69
Total Value
$9.12M
Shares Held After
7,648,829
% of Holdings
10.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Farrow Jeffrey S
— Chief Financial Officer and Chief Strategy Officer
Mar 19, 2026
Sale
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Neervannan Seshadri
— Chief Operating Officer
Mar 19, 2026
Sale
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Lin Elizabeth Yeu
— Chief Medical Officer
Mar 19, 2026
Sale
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Whitfield Dianne C.
— Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Mottiwala Aziz
— Chief Commercial Officer
Mar 19, 2026
Sale
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tarsus Pharmaceuticals, Inc.
(TARS)
Wahl Bryan
— General Counsel
Mar 19, 2026
Sale
Shares
4,231
Price
$67.00
Total Value
$283.48K
Shares Held After
63,959
% of Holdings
6.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Wagner Andreas P.
— Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
11,602
Price
$18.22
Total Value
$211.40K
Shares Held After
148,628
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Nouri Alaleh
— EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
2,332
Price
$26.15
Total Value
$60.97K
Shares Held After
105,354
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROCEPT BioRobotics Corp
(PRCT)
Nouri Alaleh
— EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
3,031
Price
$25.82
Total Value
$78.26K
Shares Held After
107,686
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Stoke Therapeutics, Inc.
(STOK)
Ticho Barry
— CHIEF MEDICAL OFFICER
Mar 19, 2026
Sale
Shares
1,461
Price
$29.99
Total Value
$43.82K
Shares Held After
40,702
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
MAHON PAUL A
— EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 51–100 of 1861 transactions (page 2 of 38)
Version: v26.3.29